Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: John DiBella; Christopher Steffen

Premium

Simulations Plus has promoted John DiBella to vice president of marketing and sales.

In his new post, DiBella will have signature authority on multiple corporate documents, including software license agreements, confidentiality agreements, and consulting and collaboration contracts, the company said.

Prior to taking on the position, DiBella held several positions at Simulations Plus including director of marketing and sales; manager of marketing and sales; senior applications scientist; and modeling and simulation scientist.


Accelrys said this week that Christopher Steffen, a member of its board of directors, has chosen not to stand for reelection when his current term expires later this year.


The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.